Skip to main content
Clinical Trials/NCT03887091
NCT03887091
Completed
Not Applicable

Use of a Video-based, Personalized Web Page as a Complement to Standard Patient Education for Clinical Trial Participants

Dana-Farber Cancer Institute1 site in 1 country99 target enrollmentJuly 21, 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
Dana-Farber Cancer Institute
Enrollment
99
Locations
1
Primary Endpoint
Number of cumulative participant caused violations over 4 cycles
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This research study is evaluating the effectiveness of video and web-based communication in clinical research compared to standard practices.

Detailed Description

Research has shown that many clinical trial participants are confused about clinical trials. Common participant misunderstandings include the idea of randomization, benefits to participants' health, the proven nature of the study intervention, and failure to recognize the primary purpose of the trial. There can sometimes be unintended miscommunication between the study doctor and/or nursing staff and participants. Thus, there is a clear need to identify ways to improve communication during clinical trials. The investigator's current culture of web-based information presentation, whether it takes the form of PowerPoint presentations, videos, websites, or audio tools, suggests that adding such technology to the cancer research realm may improve a participant's clinical trial experience and possibly improve participant understanding and safety while enrolled on a clinical trial. Video and web-based tools in cancer research have the potential to transform clinical trial practice.

Registry
clinicaltrials.gov
Start Date
July 21, 2014
End Date
May 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mary-Ellen Taplin, MD

Prinicipal Investigator

Dana-Farber Cancer Institute

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Number of cumulative participant caused violations over 4 cycles

Time Frame: 168 Days

Wilcoxon Rank Sum Test (one-sided alpha = 0.10).

Secondary Outcomes

  • Participant reported outcomes (PRO) center on treatment satisfaction(PROs collected on Cycle 1 Day 1 and each day 1 of a cycle thereafter until Cycle 7 Day 1, approximately over the course of 7 months.)
  • Number of times participants accessed the webpage(126 Days)
  • number of participant-caused protocol violations(168 Days)
  • Participant reported outcomes (PRO) on Perceived Stress(PROs collected on Cycle 1 Day 1 and each day 1 of a cycle thereafter until Cycle 7 Day 1, approximately over the course of 7 months.)

Study Sites (1)

Loading locations...

Similar Trials